FA. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction.
ONE FACTOR THAT WILL CRITICALLY influence the progress of cardiac regenerative medicine in the future is the availability of adequate technologies to track the fate of stem cells in intact hearts. An ideal in vivo evaluation of regenerating myocardium would combine localization and tracking of transplanted stem cells with the quantification of morphological and functional changes. Although not devoid of limitations, cardiac MRI, to date, stands out as the technique that better matches those requirements. Stem cells can be labeled with superparamagnetic iron oxide nanoparticles before their delivery and then detected by cardiac MRI in vivo (2, 17, 23, 25, 27, 28) . Unfortunately, iron oxide nanoparticles present important disadvantages such as potential cell toxicity, accumulation in myocardial interstitial tissue after labeled cell death, and progressive dilution as cells replicate (2, 48) . A better alternative to tagging with inorganic material is cell transduction with reporter genes, which are only expressed by viable cells and, if stably incorporated into the genome, can follow cell division cycles and be put under the control of specific promoters (26) . In vivo reporter gene technology has been thus far mainly utilized for radionuclide imaging (6, 22) , whereas its application to MRI is still underdeveloped and not tested in the cardiovascular field. The iron-binding protein ferritin is a promising reporter gene for MRI, as indicated by recent neurological and oncological studies (10, 36) . Its overexpression causes intracellular iron accumulation and, consequently, may generate areas of relative tissue hypointensity on T2-and T2*-weighted images. The aim of the present study was to test whether the overexpression of human ferritin heavy chain (hFTH) in cardiospheres (Cs), which are clusters of cardiac stem and progenitor cells (32, 44) , allows their long-term tracking by 1.5-Tesla MRI after transplantation in healthy and infarcted rat hearts and whether this reporter gene interferes with Cs capacity to restore cardiac function and structure. Since this study was focused on the reliability of ferritin as a cardiac MRI reporter gene, we needed to avoid confounding results due to uncertain stem cell efficiency. Therefore we chose Cs, which were first developed by us (32) and display a well-documented cardioregenerative potential (47) . Cs were obtained from pig hearts and delivered to rat hearts. Xenotransplantation was very useful for postmortem histological tracking of exogenous cells.
MATERIALS AND METHODS
Cs preparation and characterization. Cs were obtained from pig myocardial biopsies as previously described (32, 44) . Five French myocardial biopsy forceps (Cordis, Haan, Germany) were advanced to the right ventricle through the right external jugular vein under fluoroscopic guidance during general anesthesia. Bioptic tissue from the interventricular septum was stored in ice-cold cardioplegic solution, then cut into fragments, washed, partially digested enzymatically, and cultured as explants on dishes coated with fibronectin (diluted 25 g/ml in sterile water; Becton Dickinson, Franklin Lakes, NJ), covered with media containing 20% FBS, 1% penicillin-streptomycin, 2 mmol/l L-glutamine, and 0.1 mmol/l 2-mercaptoethanol in Iscove's Modified Dulbecco medium (IMDM; called 20% cardiac explant medium or 20% CEM) and maintained at 37°C (32) . After several days, small, round, phase-bright cells arose from the explants and migrated over a layer of stromal-like cells. These phase-bright cells, named cardiosphere-forming cells, were harvested and seeded on poly-D-lysine-coated dishes in cardiosphere growing medium [35% IMDM and 65% DMEM/F-12 Mix (Invitrogen), 3.5% FBS, 1% penicillin-streptomycin, 1% L-glutamine, 0.1 mmol/l 2-mercaptoethanol, 40 nmol/l thrombin, B-27, 20 ng/ml bFGF, 10 ng/ml EGF, and 40 nmol/l cardiotrophin-1]. Several days later, the cells that remained attached to the dishes were discarded, whereas detached Cs were plated on fibronectin-coated flasks and expanded as mono-layers of cells, named cardiosphere-derived cells (CDCs), which were subsequently passaged two to three times in 20% CEM and then subjected to lentiviral transduction (44) . CDC were characterized by flow cytometry to detect the expression of porcine c-kit (mouse anti-CD117, antibodies-online GmbH, 52072; Aachen, Germany) and CD105 (mouse anti-CD105; Abcam, Cambridge, UK) antigens, as previously described (44) . After transduction, 1 ϫ 10 6 CDCs were again seeded on poly-D-lysine-coated dishes in cardiosphere growing medium; 3 days later, the formed Cs (n ϭ ϳ200) were collected, suspended in sterile PBS, and transplanted.
Lentiviral vectors. The self-inactivating vector LAW34 used to deliver hFTH gene was produced from feline immunodeficiency virus, as previously described (41) . The hFTH cDNA was provided by Professor Paolo Arosio (University of Brescia, Italy) and cloned between cytomegalovirus constitutive promoter and postregulatory element of woodchuck hepatitis by RT-PCR amplification. The derived construct, LAW34-hFTH, was checked for proper insertion and absence of unwanted mutations in hFTH and flanking sequences by cycle sequencing. Vesicular stomatitis virus glycoprotein G (VSV-G) pseudotyped particles were generated in human embryonic kidney 293-T cells cotransfected with: 1) packaging plasmid pDEnv1, providing FIV capsid and enzyme proteins; 2) VSV-G plasmid, providing the viral envelope; and 3) vector plasmid. A detailed description of pDEnv1 and VSV-G plasmids, transfection protocol, and safety tests to rule out generation of infectious particles, incorporation of pDEnv1 into progeny particles, and inactivation of vector long terminal repeats is available elsewhere (41) . We employed the following vector plasmids: LAW34-hFTH, for in vivo tests; LAW34-BRCA1, encoding for the breast cancer associated gene type-1, as nonrelated control; LAW34-GFP, encoding for the green fluorescent protein (GFP), for in vitro tests. The supernatant of transfected 293-T cells was collected 48 -72 h post-transfection, clarified by centrifugation, filtered, and stored at Ϫ80°C in small aliquots until use. LAW34-GFP, LAW34-BRCA1, and LAW34-hFTH pseudotyped particles were quantified by testing reverse transcriptase activity (40) and titrated in 293-T cells by flow cytometry (40) . Titers were expressed as number of transduction units (TUs) per milliliter.
Transduction of progenitor cells. The swine CDCs were seeded at 3 ϫ 10 5 /well in six-multiwell plates and transduced 24 h later with 3 ϫ 10 6 TUs LAW34-GFP or equivalent amounts of LAW34-hFTH and LAW34-BRCA1. Vector supernatant was replaced with fresh medium 4 h later, and cells were further incubated for 48 h. The efficiency of transduction with LAW34-GFP was determined by flow cytometry. Expression of LAW34-hFTH transgenes was evaluated by RT-PCR in total RNA extracted from transduced cells with RNAeasy mini kit (QIAgen, Milan, Italy).
Evaluation of cell viability, replication, and expression of surface markers after transduction. Viability of CDCs, either transduced with LAW34-hFTH or LAW34-BRCA1 or mock transduced (i.e., supernatant from nontransfected 293-T cultures), was monitored at days 1, 2, 3, 5, 6 , and 7 by staining cells with Trypan blue, which permeates only dead cells, whereas cell proliferation was assessed using carboxyfluorescein succinimidyl ester (CFSE), a fluorescent dye stably retained by viable cells (37) . For Trypan blue assay, cells were tripsinized at the indicated days, stained with 10% Trypan blue and counted under light microscope to determine the percentage of viable cells. For CFSE assay, tripsinized cells were seeded in a 24-multiwell plate and incubated with 20 mol/l CFSE at day 0. CFSE-stained cell counting was performed at the indicated days by flow cytometry. To evaluate the expression of porcine c-kit and CD105 CDC antigens, connexin-43, and GATA-4 cardiac lineage antigens, CDCs were incubated with mouse anti-CD117, mouse anti-CD105, rabbit anticonnexin-43 (Cell Signaling Technology) for 1 h at 37°C, washed twice with fluorescence-activated cell sorting (FACS) buffer, incubated for 1 h at room temperature with anti-mouse IgG-RPE antibody, washed twice with FACS buffer and analyzed by flow cytometry. The porcine GATA-4 expression was detected by immunocytochemistry using specific antibody (goat anti-GATA-4, 1:50; R&D Systems).
In vitro Prussian blue staining. To assess iron accumulation in CDCs in vitro, samples of 10 5 cells (both transduced and nontransduced) were cultured on a multiwell plate in 20% CEM or 20% CEM plus 100 mM/l ferric ammonium citrate (FAC; Sigma, Steinheim, Germany) (11). After 5 days, the cells were fixed with 3% paraformaldehyde (Sigma), washed with PBS, and subjected to Prussian blue staining.
Myocardial infarction and cell delivery. Myocardial infarction was produced in male adult Wistar rats as previously described by us (15, 30, 52) . The rats were anesthetized with a combination of tiletamine and zolazepam (Zoletil; Virbac, Carros, France), intubated, and ventilated, and the left anterior descending coronary artery was permanently ligated with 6-0 prolene thread. Forty-five minutes later, pooled Cs were first resuspended in 200 l of PBS and then injected intramyocardially with an insulin syringe, through a 21-gauge needle, into the border of the visually recognizable ischemic area. Two injections of 100 l of Cs suspension were performed to deliver ϳ200 Cs per heart. Control infarct hearts were injected with the same volume of vehicle, i.e., PBS. After intramyocardial injection of Cs, the chest was closed, pneumothorax was reduced, and the animals were treated with aspirin (100 mg/kg orally every 24 h) during postsurgical recovery.
The rats were randomly assigned to the following three treatments: hFTH-transduced Cs [myocardial infarction (MI) ϩ hFTH-Cs group; n ϭ 17], nontransduced Cs (MI ϩ Cs group; n ϭ 6), or PBS (MI ϩ PBS group; n ϭ 7). Another group of animals was sham operated and also received ϳ200 hFTH-transduced Cs (Sham ϩ hFTH-Cs group; n ϭ 5). The rats underwent MRI assessments at 1 and 4 wk following Cs injection and were then euthanized, and the hearts were collected for histological analysis. Five of the MI ϩ hFTH-Cs rats were euthanized at 1 wk after Cs delivery, and histological analysis was performed to test the presence of iron accumulation in engrafted cells at this early time point. Finally, a group of infarcted female rats (n ϭ 5) was intramyocardially injected with ϳ200 hFTH-transduced Cs obtained from male pigs and euthanized 6 wk later for subsequent tissue analyses. Experimental protocols were approved by the Animal Care Committee of the Italian Ministry of Health, in accordance with Italian law (DL-116; January 27, 1992) .
MRI morphological and functional analysis. In vivo MRI was performed using a clinical 1.5-T MR scanner (Signa HDx; General Electric Health Care, Milwaukee, WI) in rats anesthetized with a mixture of tiletamine and zolazepam. Cardiac morphological and functional cine images data were acquired by an ECG-triggered steady-state free precession (SSFP) pulse sequence (FIESTA) with the following parameters: field of view (FOV) ϭ 20 ϫ 20 mm, slice thickness ϭ 4 mm, no gap, number of excitation (NEX) ϭ 5, views per segment ϭ 2, echo time/repetition time (TE/TR) ϭ 1.6/3.2, flip angle (FA) ϭ 45°, matrix ϭ 192 ϫ 192, and reconstruction matrix ϭ 256 ϫ 256. For each view 10 cine-frames were acquired. A total of five short-axis views (to completely scan the ventricular main axis in end diastole) and four long-axis views (1 vertical, 1 horizontal, and 2 oblique long-axis views) were acquired according to a method specifically adapted to rodent hearts, previously used by us and by others (16, 30) . Left ventricular (LV) end-systolic and end-diastolic volume index, mass index, ejection fraction, and end-systolic wall thickening were measured and calculated from the cine-images with previously validated software (Mass 6.1; MEDIS, Leiden, The Netherlands). End-systolic wall thickness (ESWT) and end-diastolic wall thickness (EDWT) were measured in the border zone and in the remote zone, and systolic wall thickening (SWT) was calculated as ESWT Ϫ EDWT/EDWT ϫ 100.
Myocardial scar imaging was obtained using the delayed enhancement technique (30) . Images were acquired 3 min after bolus injection of gadobutrol (Gadovist, Schering, Germany), 0.02 mmol/100 grams of body weight, in the same short-axis and long-axis slices was used for cine MRI, with an ECG-triggered fast gradient echo inversion recovery pulse sequence, using the following parameters: TR ϭ 4.2 ms, TE minimum, FA ϭ 20°, matrix ϭ 192 ϫ 192, NEX ϭ 5 , FOV 20 ϫ 20 mm, slice thickness 4 mm, no interslice gap, 1 R-R interval. The inversion time was fixed to 100 ms and eventually optimized to null signal from the normal myocardium when appropriate (16, 30) .
Holding as a reference the myocardial scar in delayed enhancement images, three regions of interest were defined: scar, border zone (myocardial region adjacent to the scar), and remote zone (myocardial region opposite to the scar). To assess the infarct size, the extent of delayed-enhanced areas was measured by employing a semi-automatic, previously validated software (Mass 6.1, as above) (30) . Contrast-enhanced regions, corresponding to the infarcted regions, were quantified in grams as well as in percentage of the mass of the entire LV. Female rats were used only to further test the longer-term survival of pig Cs-derived cells transduced with hFTH; therefore, their cardiac function was not assessed.
Detection of iron accumulation by MRI. Magnetic field nonhomogeneities caused by iron accumulation were detected by measuring myocardial T2-star (T2*), a transverse relaxation parameter that includes the contribution of magnetic field nonhomogeneities. Iron accumulation causes a reduction in myocardial T2* and is diagnosed when T2* Ͻ20 ms (53) . This measurement was performed by a T2*-weighted gradient-echo sequence (T2*-GRE) with multiple echo times (TE), with the following parameters: FOV ϭ 20 ϫ 20 mm, slice thickness 4 mm, no spacing between slices, FA ϭ 25°, TR ϭ 19.8 ms, six echo times (2-13 ms, echo spacing 2.2 ms), NEX ϭ 5, views per segment 2, matrix ϭ 192 ϫ 192, and reconstruction matrix ϭ 256 ϫ 256, according to a method previously employed by us and others (13, 38, 39, 43, 53) . Because fast cardiac rates preclude the use of sufficiently long echo times, we first tested the effects of ferritin overexpression on T2* in vitro (24) . hFTH-transduced (1 ϫ 10 6 ) and nontransduced (1 ϫ 10 6 ) CDCs were cultured in 20% CEM or 20% CEM plus 100 mM FAC. After 5 days, the cells were trypsinized, centrifuged, and resuspended in 0.5 ml of 1% agarose in four Eppendorf tubes of 0.8 cm in diameter and scanned with the clinical 1.5-T MR scanner. The region of interest for signal intensity (SI) was 17 mm 2 . The SI was assessed at increasing TE from 2 to 20.9 ms, and we considered T2* Ͻ20 ms due to iron accumulation.
In vivo myocardial iron accumulation was sought and quantified, by 1.5-T MRI, at 1 and 4 wk after cell delivery. In this case, we obtained ECG-triggered T2*-GRE with multiple TE (38, 53) . Images were acquired in the same long-axis and short-axis views as for the cine images, according to the following procedure (Fig. 1) . First, we outlined the cardiac wall borders based on the SSFP image. This anatomical image was then automatically replicated and used as a spatial reference in all of the T2*-GRE multiecho images, in which the definition of cardiac contours became progressively blurrier. Myocardial T2* was measured both in the border zone and the remote zone as follows: the calculated decay curve was fitted to the monoexponential model, i.e., S ϭ S 0e ϪTE/T2* , where S is the signal intensity, TE is the echo time, S 0 is the signal value at TE ϭ 0, and T2* is the transverse relaxation time constant; a linear fitting of the signal logarithm allowed calculating the T2* value in each region.
In T2*-GRE images, the susceptibility artifacts due to the presence of iron enrichment appear as areas of hypointensity (signal void), which progressively increase with increasing TE (Supplemental Fig.  S3 and Video S1), extending even beyond the myocardial wall (blooming effect). Therefore, we outlined and measured the area of hypointensity at the minimum TE that allowed its clear identification and most conservative estimate of the extent of myocardial iron accumulation (2 ms in Fig. 1 ). Since Cs were injected in the distal LV segments, in rats the signal void was better identified and measured in long-axis views.
Histology, immunohistochemistry, immunofluorescence, and TUNEL. At the end of in vivo studies, the animals were euthanized, and the hearts were excised, fixed in 10% buffered formalin, and embedded in paraffin. Five-millimeter-thick transverse sections were cut through the short axis of both ventricles at basal, midseptal, and apex level. The midseptal section was performed in correspondence of the left ventricular papillary muscle. Serial, 3-m-thick slices were cut and processed for histological, immunofluorescence, and immunohistochemical analysis. Each slice included the entire LV cross section at that level. The area comprising 10% of the spared myocardium adjacent to the fibrotic tissue of transmural infarcts was identified as the border zone, and the viable myocardium opposite to infarct scar was considered as the remote zone, as previously described (35) . Iron was detected using Prussian blue staining (Perls) with nuclear-fast red counterstaining.
The colocalization of markers of specific cell lineages was tested by immunofluorescence. To identify cells deriving from Cs, we utilized a monoclonal swine-specific mitochondrial Mit marker (mouse anti-mitochondria antibody, 1:50; Abcam, Cambridge, UK). Serial sections were also treated with antibodies directed against the endothelial cell marker CD31 (mouse anti-CD31, 1:100; Dako, Glostrup, Denmark), the cardiomyocyte markers troponin-T (antitroponin T, 1:50; Histoline Lab, Milan, Italy), the smooth muscle marker ␣-actin (mouse anti-␣-SMA, 1:400, clone 1A4; Dako), the cardiomyocyte marker ␣-sarcomeric actin (mouse anti-␣-SA, 1:100; Abcam), and the proliferation marker Ki-67 (1:100; Dako). After being washed in PBS containing 0.1% Triton X-100 and 1% BSA, the tissue slices were incubated with the nuclear dye Hoechst (SigmaAldrich, Milan, Italy), anti-rabbit (1:1,000; Chemicon, Milan, Italy), and/or anti-mouse secondary antibodies (1:1,000; Invitrogen) and mounted with Vectashield medium (Vector Laboratories), as previously described (1). The immunofluorescence for Mit and ␣-SA colocalization was obtained as previously described (29) . Confocal microscopy was performed with a Leica TCS DMIRE 2 (LCS Lite Software; Leica, Wetzlar, Germany). No significant fluorescent signal was detectable with any of the secondary antibodies alone. First, we sought the possible colocalization of the mitochondrial marker Mit with Perls positivity. We then assessed the colocalization of Mit with the other lineage markers. Quantification of immmunofluorescent cells was obtained by at an original magnification of ϫ400 on at least five randomly selected fields of infarct, border, and remote zone. In particular, for quantitative analysis, images of the region of interest were taken at original magnification (ϫ400) and analyzed using the Image-Pro Plus 4.5 software.
Myocardial inflammation was assessed by immunohistochemistry using an antibody directed against the monocyte-macrophage marker CD68 (mouse anti-CD68, 1:100, clone KP1; Dako), the rodent panleukocyte marker CD45 (rabbit anti-CD45, 1:100; Abcam) and the naphthol AS-D chloroacetate esterases assay (Sigma-Aldrich) to detect infiltrating neutrophils (5) . For quantification, the number of CD45-positive cells and neutrophils were counted in at least five randomly selected high power fields (magnification, ϫ200) in five independent samples from each group. The slices, hybridized with primary antibody, were subsequently incubated with biotinylated secondary antibody and detected by the streptavidin-biotin method using a labeled streptavidin-biotin (LSAB) kit (Dako, Kyoto, Japan). For negative controls, sections were incubated in parallel with the secondary antibody alone.
We also sought the potential overexpression of VEGF-A, one of the most important paracrine factors released by stem cells in the heart (19) . Tissue sections were incubated with rabbit-anti-VEGF-A (1:200, sc-152; Santa Cruz Biotechnology) overnight at 4°C. The sections were counterstained with hematoxylin (49) .
Finally, cell apoptosis was screened by TUNEL assay according to instructions of the manufacturer (In Situ Cell Death Detection Kit, POD; Roche Applied Science).
Fluorescence in situ hybridization and PCR of the specific sex determining region DNA. To further confirm the successful engraftment of xenotranplanted cells in our model, fluorescence in situ hybridization (FISH) assays for the chromosome Y were performed in female rat hearts that received male pig Cs, as previously described by us (33) and by others (9, 45) . Briefly, 4-m-thick LV formalin-fixed sections were placed on glass slides pretreated with 3-aminopropyltriethoxysilane and then allowed to dry. Sections were placed in protease solution and incubated at 37°C for 15 min. Following digestion, the sections were washed and dehydrated with a series of graded alcohols. Hybridization of the tissue with the probe was performed at 37°C for 24 h, as recommended by the manufacturer of the probe (Vysis from Abbott Molecular). Tissue sections were tested with a SpectrumGreen-labeled fluorescent centromeric enumeration DNA probe specific for satellite III DNA at the Yq12 region of chromosome Y (Vysis from Abbott Molecular), counterstained with 4,6-diamino-2-phenylindole (DAPI; Vysis from Abbott Molecular), and then examined with an Olympus BX-61 microscope (Olympus America, Melville, NY). They were scanned at low magnification (100ϫ) with DAPI excitation to localize those areas whose histopathological characteristics had been established by examining the Prussian blue staining with nuclear-fast red counterstaining. The hybridization signal for the Y chromosome appeared as a green dot within the nuclear area. 2 rows) . SSFP allowed the identification of cardiac walls in a 4-chamber view; hence it was used as the anatomical reference for T2* images, characterized by a progressively increasing hypointense area (white arrows) only in the border zone of the rat transplanted with hFTHCs, due to iron accumulation. DE indicates the presence of a myocardial scar in both hearts (black arrows). LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right atrium.
RT-PCR analysis of laser-captured Perls-positive was performed to confirm the presence of Y chromosome-specific sex determining region gene (SRY). Laser capture microdissection was performed on tissue sections (4 m) stained for iron from formalin-fixed and paraffin-embedded specimens (50) . Laser-capture microdissection of Perls-positive cell populations from cardiac border zone of female rats 6 wk after Cs transplantation was performed using the PALM Laser MicroBeam system (PALM, Bernried, Germany). Only 300 -400 Perls-positive cells were harvested. An equal amount of Perls-negative cells collected from remote zone of infarcted female rats were used as negative control. After collecting the cells into the lid of a 0.5-ml reaction tube, total RNA was extracted by using Rneasy Midi kit (Qiagen S.p.A, Milano, Italy), and SRY gene was assayed by RT-PCR. The primers for sus scrofa SRY were: forward primer 5=-GACAAT-CATAGCTCAAACGATG-3= and reverse primer 5=-TCTCTAGAGC-CACTTTTCTCC-3= (133 bp). GAPDH mRNA was used as housekeeping gene. The primers for sus scrofa GAPDH gene were: forward primer 5=-ACCACAGTCCATGCCATCAC-3= and reverse primer 5=-TCCAC-CACCCTGTTGCTGTA-3= (451 bp). The PCR analysis was performed in duplicate.
Statistical analysis. Data are presented as means Ϯ SEM. Statistical analysis was performed by employing commercially available software (SPSS for Windows, version 11.1; SPSS, Chi- cago, IL). Differences between groups were assessed by one-way and two-way ANOVA followed by the Bonferroni post hoc test. For all the statistical analysis, significance was accepted at P Ͻ 0.05.
RESULTS

Efficacy and stability of CDCs transduction with hFTH.
LAW34 transduction efficiency was preliminarily tested by incubating CDCs with LAW34-GFP for 4 h. Analysis of GFP-positive cells, performed 48 h post-transduction, showed that LAW34 was able to transduce CDCs with an efficiency of 20% and that GFP expression remained stable throughout a 2-wk observation period (Supplemental Fig. S11 ). Since this result was achieved with no double transduction, addition of polybrene, vector ultracentrifugation, cell spinoculation, or other expedients known to increase efficiency of transduction (14) , LAW34 was deemed a vector suitable for the purpose of our study and therefore used to deliver hFTH to swine CDCs. hFTH mRNA was already detectable by PCR 2 days after delivery ( Fig. 2A) , and transgene expression was stable throughout a 2-wk observation period.
Effects of hFTH transduction on cell viability, proliferation, and surface antigen profile. To rule out detrimental effects of CDCs transduction with hFTH, we monitored their viability and proliferation up to 1 wk post-transduction. As shown in Fig. 2B , trypan blue staining, which is notoriously limited to dead cells, showed that there were no appreciable differences between transduced and not transduced cells. Similarly, CFSE staining, which covalently binds viable cells and is not transmitted to cell progeny, gradually decreased over time in all cell cultures regardless of their treatment (Fig. 2C) . Finally, since some vectors have been reported to change the antigenic profile or initiate the differentiation process of progenitor cells (40, 51) in pilot studies we investigated the pattern of cell surface markers expression, before and after transduction. We confirmed CDCs expression of c-Kit and CD105, progenitor markers; GATA-4, a cardiomyocyte lineage transcription factor; and Connexin-43, a surface protein expressed in more differentiated cardiomyocytes, as previously found by us (32) . Re- Fig. 4 . Quantitation of iron accumulation by MRI. A: progressive reduction of signal intensity for hFTH-transduced CDCs cultured in the presence of ferric ammonium citrate (FAC; hFTH-CDCs ϩ FAC) or in CEM (hFTH-CDCs). T2* displayed a faster decrease for hFTH-CDCs ϩ FAC, indicating the presence of iron overload. B: increased transverse relaxivity (decreased T2*), indicating iron accumulation, in the cardiac border zone (injection site) compared with the remote zone of male (n ϭ 9) and female (n ϭ 5) rats with myocardial infarction (MI) that received hFTC-transduced Cs. T2* was not significantly different in the border zone of rats with nontransduced Cs (n ϭ 6) compared with remote myocardium. C: area of magnetic susceptibility artifacts in T2*-weighted cardiac images acquired at 1 and 4 wk after delivery of hFTC-transduced Cs in sham (n ϭ 5) and infarcted (MI) rats (n ϭ 5). The area of hypointensity in female rats scanned at 6 wk after hFTC-transduced Cs delivery was comparable with the other group. gardless of the cell marker we considered, the surface antigen profile did not change following transduction, indicating that, at least for the markers tested, both LAW34 and hFTH did not appreciably alter CDCs staminality (data not shown).
In vitro prussian blue staining. Prussian blue staining of CDCs cultured in 20% CEM, which is an iron-poor media, showed no iron accumulation in both hFTH-transduced and nontransduced cells. When 100 mM FAC was added to CEM, iron accumulation was observed only in hFTH-transduced CDCs (Fig. 3) . Therefore, hFTH overexpression could cause intracellular iron accumulation, in vitro, before transplantation; however, this did not occur in our cultures, since we always used CEM as a medium.
In vitro relaxometry. As shown in Fig. 4A , the analysis of T2* weighted images demonstrated a faster decrease of TE signal intensity, over 21 ms, for ferritin-transduced CDCs cultured in the presence of FAC compared with transduced CDCs cultured in CEM. The addition of FAC to culture medium did not affect the signal intensity in nontransduced CDCs, indicating a ferritin-specific effect on T2*. Therefore, the MRI artifact was not induced by the cell mass per se, or by FAC.
In vivo stem cell tracking by MRI. We performed morphofunctional and T2* MRI studies in all groups of animals at 4 wk after Cs delivery and, in the animals that received hFTHCs, also at 1 wk after transplant. The female rats receiving hFTH-Cs from male pigs underwent MR scanning only at 6 wk after Cs delivery. As shown in Fig. 4B , transverse relaxivity (decreased T2* time), indicating iron accumulation, was significantly higher in the border zone (injection site) compared with the remote zone in rats that received hFTH-Cs, whereas no differences were found in rats with nontransduced Cs. Well-defined areas of hypointensity were observed in the anterior wall of the Sham ϩ hFTH-Cs group and in the border zone of the MI ϩ hFTH-Cs group, but not in animals that received nontransduced Cs or PBS (Fig. 4C) . These areas did not vary significantly at 4 compared with 1 wk, indicating a stable diffusion of Cs-derived cells in host myocardium. No significant changes were observed in the LV remote zone of any of the experimental groups.
LV function and infarct scar quantification by MRI. As shown in Fig. 5 , A-C, MRI indicated a better preserved LV global function in all rats subjected to Cs delivery; LV regional function analysis showed also a better preserved systolic wall thickening in the border zone where Cs were injected compared with the animals that received PBS. The infarct scar was smaller in the Cs-treated animals. Importantly, no significant differences were observed between the groups that received transduced or nontransduced Cs, suggesting the lack of deleterious effects of hFTH transduction on Cs reparative capacity. The LV ejection fraction at 6 wk after Cs injection was not significantly different compared with the 4-wk time point (36.2 Ϯ 5 vs. 37 Ϯ 2.4%).
Histological iron localization and immunofluorescence-detected colocalizations. Prussian blue positive staining was detected in the border zone of the MI ϩ hFTH-Cs group at 1 and 4 wk after cell delivery (Fig. 6, A and B) , but not in MI ϩ Cs and MI ϩ PBS groups (Fig. 6C) , and no iron staining was found in the remote zone. The number of Perls-positive cells was 63.2 Ϯ 4.2 at 1 wk and did not change significantly at 4 wk (55 Ϯ 3.4 cells/field; n ϭ 5 per group; not significant), consistent with the MRI data. Swine Mit positivity was observed in all animals receiving transduced or nontransduced Cs. Immunofluorescence analysis showed colocalization of Prussian blue staining and swine mitochondrial Mit antigen (Fig. 7A) , indicating the exogenous origin of iron-accumulating cells. Mit positivity was always more diffuse than iron staining, with an ϳ3:1 ratio, consistent with the transduction efficiency. Moreover, Mit colocalized with CD31, ␣-SA, and ␣-SMA (Fig. 7, B-D) in all hearts transplanted with Cs, indicating that porcine Cs-derived cells differentiated into endothelial, smooth muscle, and cardiomyocyte lineages regardless of their transduction with ferritin transgene. Mit was present in 70 Ϯ 8% of CD31-positive cells, in 25 Ϯ 6.6% of ␣-SMA-positive, and only in 5 Ϯ 1% of ␣-SA-positive cells, as shown in Supplemental Fig. S3 . On the other hand, we could not detect any association between swine Mit and troponin T positivity. In addition, no evidence of ki-67 co-staining, a well-established proliferation marker (21) , was found in Perls-/Mit-positive cells engrafted in the injected myocardium. Control samples treated with secondary antibody alone did not exhibit any specific staining.
FISH and RT-PCR. FISH for the Y chromosome was detected in matched Perls-positive cells in specimens from female hearts 6 wk after transplantation with male Cs (Fig. 8A) . The presence of Y chromosome in Perls-positive cells was confirmed by RT-PCR analysis of SRY gene in laser-captured cells from infarcted female hearts (Fig. 8B) .
Inflammation and apoptosis. No significant differences among groups were found in the number of CD45-positive cells and neutrophils infiltrating the myocardium at 4 wk after Cs delivery (Fig. 9 , B and C).
Although, rare CD68-positive cells were found at 1 wk and even rarer at 4 wk after infarction (Fig. 9D) . We did not find any evidence of apoptotic cells (TUNEL-positive cells) in the myocardium.
VEGF-A. As shown in Supplemental Fig. S4 , myocardial expression of VEGF-A was increased in infarct border zone at 1 wk after Cs delivery, associated with putative vessels, but not in the PBS group. This overexpression was no longer present at 4 wk after Cs delivery.
DISCUSSION
The present study shows that ferritin heavy chain can function as a reliable and safe reporter gene to track stem/progenitor cells in vivo. Ferritin overexpression in engrafted Cs yielded iron accumulation that could be precisely localized, in rat hearts, with a clinical standard 1.5-T MR scanner and was confirmed histologically by Prussian blue staining. Importantly, histological analysis documented a colocalization of iron accumulation with the pig-specific mitochondrial marker Mit, strongly supporting the porcine origin of these cells. Moreover, Mit colocalized with antigens specific for endothelial, smooth muscle, and cardiac muscle cell lineage in hearts transplanted with nontransduced or transduced Cs, indicating that ferritin overexpression did not impair the differentiative potential of exogenous cardiac stem cells. The survival of xenogeneic cells up to 6 wk was further confirmed by the presence of Y chromosome, in female rat hearts, after delivery of Cs obtained from male pigs.
Cardiosphere tracking with MRI. Due to its relatively high spatial resolution and its ability to simultaneously quantify myocardial function and infarct size and to detect stem cells labeled with contrast agents, cardiac MRI is currently the best available technology to monitor the effects of stem cell therapy in infarcted hearts. Thus far, cell tracking with MRI has relied on cell preloading with superparamagnetic iron oxide nanoparticles (SPION) before their implantation in hearts (2, 17, 23, 25, 27, 28) . However, this technique has two important limitations: 1) the label gets diluted as the cell replicates and 2) the label may be taken up by macrophages after cell death and thus confound the interpretation of MRI data. Amsalem et al. (2) and Terrovitis et al. (47) studied the correlation between the MRI signal and the actual survival and engraftment of SPIONlabeled stem/progenitor cells implanted into acutely infarcted rat hearts. In both studies, MRI signal corresponding to iron accumulation could be detected at 4 or 3 wk post-implantation; however, the post-mortem histological analysis did not confirm the presence of iron in cells of exogenous origin, but rather in endogenous macrophages that engulfed the SPION. This aspect is particularly relevant to regenerative therapy, since it is known that a large portion of stem cells die soon after their delivery to the heart, due to trauma and hostile environment (12, 34) . Given such limitations, we tested a method for cell tracking based on a completely different approach. Ferritin has been previously proposed as a reporter gene for MRI (4, 10, 17, 31, 36) , although the full potential of this technology in the field of stem cell therapy is still virtually unexploited. Ferritin sequesters up to 4, 500 atoms of iron per molecule, a function that is mainly regulated by the heavy chain sub-unit (46) . An increased expression of ferritin shifts the intracellular iron distribution toward the ferritin-bound form, thus inducing compensatory increases in iron uptake and cellular iron content, while, at the same time, protecting against damage from reactive oxygen species (11) . Iron accumulation can be detected in T2-and T2*-weighted MR images; therefore ferritin overexpression causes a well circumscribed MRI signal, obviating the need for contrast agent administration (10, 17) . In our study, the lentiviral-mediated transduction of only 20% of stem/progenitor cells with hFTH was sufficient to obtain a clear MRI signal typical of iron accumulation, both in healthy and infarcted rat myocardium. The histological analysis confirmed the presence of iron deposits in the hearts where magnetic susceptibility artifacts were detected, and these deposits corresponded mostly to cells positive for a swinespecific mitochondrial marker, hence derived from transplanted Cs. On the other hand, macrophages were very few and scattered, so we could safely exclude major non-Cs-related MRI signals. The longitudinal tracking of iron-accumulating cells with MRI indicated the absence of a significant expansion of the artifact area at 4 wk compared with 1 wk after cell transplantation, consistent with the histological count of Perlspositive cells. This is an important finding of our study and highlights the usefulness of in vivo imaging to obtain at least an estimate of ongoing processes of cell proliferation and death. It is possible that, after differentiation of the initial pool of Cs into mature cells, these latter remained numerically stable. Other interpretations are also possible, but in any case the MRI data allowed us to predict, even before histological analysis, that the limited expansion of pig-derived cells could account only in part and indirectly for the extensive cardiac regeneration, as recently reported (8) . Although the in depth analysis of post-engraftment Cs differentiation was beyond the scope of the present study, our histological data clearly show that swine cells expressed mostly endothelial and, to a lesser extent, ␣-SMA antigens, and ␣-SA, as previously found by us (32) . Our findings are in accord with a recent study demonstrating that sphere-derived cells from various tissues differentiate mainly into endothelial cells (20) . Other stem cell types might display completely different patterns of differentiation and proliferation compared with Cs and would have perhaps led to different evolutions of MR images over the follow-up period.
Safety of ferritin as a reporter gene for cell therapy. An ideal reporter gene should be innocuous to the transduced cells. Our in vitro experiments ruled out deleterious effects of hFTH gene transduction on cell survival and proliferation. These results were consistent with the in vivo data, which showed similar beneficial effects of transduced and nontransduced Cs on LV global and regional function and structure. Further evidence of safety is provided by previous studies that employed ferritin heavy chain as a reporter gene for MRI. They did not detect any interference of ferritin overexpression with tumor cells growth (4, 10, 17, 36) or embryonic stem cells proliferation and differentiation (31) . Even after 2 years of overexpression in hepatocytes of transgenic mice, ferritin did not cause any liver damage (56) , strongly supporting the long-term safety of this reporter gene.
Limitations. Several limitations of the present study must be pointed out. The first limitation is the relatively short follow-up period after infarction and stem cell transplantation, which is similar to the time frame of many other studies on infarcted rodents, but perhaps insufficient to test the long-term reliability of this reporter gene system. A second limitation is the relatively low resolution allowed by a diagnostic 1.5-T MR scanner for imaging of small animals such as rats; however, the T2* sequence that we adopted for iron detection has not been validated with magnetic fields Ͼ1.5T and, at present, is the best technique available for iron detection by MRI (3). Predictably, it can be rapidly transferred to large animal studies. A third aspect that should be considered is the possibility that the iron is better detectable in Cs because they form clusters. However, in pilot experiments, we tested our method using placenta-derived stem cells (52) and, also in that case, we found well-detectable iron-induced hypointensity, consistent with the presence of iron-accumulating viable cells (Supplemental Fig. S2 ), suggesting that ferritin might be utilized as a MRI reporter gene in various stem cell types. Finally, a problem might have been caused by the use of xenogeneic cells in fully immunocompetent rats. However, the present data seem to rule out deleterious consequences due to species differences, in accord with previous studies demonstrating that xenotransplantation of cardiac stem cells did not affect the functional benefits and the efficiency of reporter gene imaging of engrafted mesenchymal stem cells (42, 44, 54, 55) . It has been also shown that the efficiency of reporter gene imaging of human mesenchymal stem cells engrafted in rodent and pig heart remained high even in the absence of immunosuppressant treatment (54) .
Conclusions
In conclusion, we provided novel evidence that a MRI-based reporter gene technology can be utilized to track dividing/ differentiating stem cells in the beating heart, while simultaneously monitoring cardiac morpho-functional changes. This technology is based on the use of lentiviral vectors and clinical standard 1.5-T MR scanners, which are available to many research centers, and might prove very useful to better address open questions in the field of cardiac cell therapy.
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